// App-Quantinova.ai

e13033 : The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy.

Researchers

Presenter

  • Edward Pearson

Principal Investigators

  • Anju Nair

  • Yahya Daoud

  • Joanne Lorraine Blum

Medical Centers

  • Baylor University Medical Center, Dallas, TX

  • Baylor Scott&White Health, Dallas, TX

  • Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart muscle disease

  • Cardiotoxicity

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved